InsidersTradesSigma
Follow the 엔젠바이오 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엔젠바이오 has published 3 insider filings. Market capitalisation: €17.6bn. The latest transaction was filed on 26 June 2026 (Sale). Among the most active insiders: 에스에이치헬스케어투자1호조합. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Enzenbio 是一家专注于健康和制药领域的公司，在 XKRX 市场上市。它致力于开发创新的生物制药解决方案。